Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership 
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation 
Same sparkle, different story: how lab-grown diamonds are transforming the market 
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints 
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer 
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover 
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race 
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges 
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners 
World game at war: why some European nations have threatened a World Cup boycott 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
IRVING, Texas, April 17, 2018 -- HMS Holdings Corp. (NASDAQ:HMSY) today announced it will report first quarter 2018 financial and operating results at 7:30 am CT / 8:30 am ET on Friday, May 4, 2018. Supplemental financial information, including the press release and investor presentation, will be released at approximately 5:00 am CT / 6:00 am ET and will also be available on the Company’s Investor Relations site at http://investor.hms.com.
| WHO: | William Lucia, Chairman & CEO Jeffrey Sherman, CFO | |
| WHEN: | Friday, May 4, 2018 7:30 am CT / 8:30 am ET | |
| HOW: | Individuals may access the webcast at http://investor.hms.com/events-and-presentations or listen to the call at (877) 303-7208. International participants may listen to the call at (224) 357-2389 | |
| REPLAY: | The webcast will be archived on the Company’s website at: http://investor.hms.com/events-and-presentations | |
About HMS
HMS is a leading provider of cost containment solutions in the U.S. healthcare marketplace. Using innovative technology as well as extensive data services and powerful analytics, the Company delivers coordination of benefits, payment integrity, and health management and consumer engagement solutions to help customers recover improper payments; prevent future innacurate payments; reduce fraud, waste and abuse; effectively engage their members and better manage the care they receive; and ensure regulatory compliance. The Company serves commercial health plans, state government agencies, federal programs, at-risk providers, pharmacy benefit managers and employers.
Investor Contact:
Dennis Oakes
SVP, Investor Relations
[email protected]
212-857-5786
